We are advised by a representative of the company that journalists and other readers should disregard the news release, Patients and Investors Now Have an Opportunity to Support Medical Innovation Through AEVOLVE, AG & FP Issuer, Ltd., issued Nov. 7, 2019 over PR Newswire, as it contained some erroneous information.

SOURCE Aevolve